Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Dp Vi Associates, L.p.


  • Large Shareholder at Ocera Therapeutics Inc. (OCRX), 2017-12-13
  • Large Shareholder at Tobira Therapeutics Inc. (TBRA), 2016-11-04
  • Large Shareholder at Colucid Pharmaceuticals Inc. (CLCD), 2016-08-03
  • Large Shareholder, Director at Syndax Pharmaceuticals Inc (SNDX), 2016-03-08
  • Large Shareholder at Marinus Pharmaceuticals Inc (MRNS), 2014-08-07
  • Large Shareholder at Aldeyra Therapeutics Inc. (ALDX), 2014-05-05
  • Large Shareholder at Cadence Pharmaceuticals Inc (CADX), 2014-03-21
  • Large Shareholder at Alimera Sciences Inc (ALIM), 2014-01-17
  • Large Shareholder at Celator Pharmaceuticals Inc (NONE), 2013-01-15
  • Large Shareholder at Zogenix Inc. (ZGNX), 2010-12-01
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
CLCD $8.15 129 Large Shareholder 3,039 2016-08-03 Filing
CLCD $8.71 32 Large Shareholder 3,168 2016-08-02 Filing
CLCD $8.82 84 Large Shareholder 3,200 2016-08-01 Filing
CLCD $6.96 235 Large Shareholder 3,284 2016-04-28 Filing
ALIM $6.56 2,230 Large Shareholder 34,907 2014-01-16 Filing